早期气管切开对机械通气吉兰-巴雷综合征患者死亡率的影响:一项全国性观察性研究
该回顾性观察研究利用日本诊断程序组合全国住院数据库(2010年7月1日至2018年3月31日),纳入成人吉兰-巴雷综合征、入院首周内启动机械通气且通气超过1周的患者。早期气管切开定义为机械通气7天内行气管切开。主要终点为住院死亡率,次要终点包括28天死亡率、院内肺炎、住院时长、ICU时长、机械通气时长、镇静/镇痛/谵妄时长及总住院费用。经稳定化逆概率治疗加权后,早期气管切开与住院死亡率降低无关(风险差0.4%;95%CI -5.6至6.7%),28天死亡率和院内肺炎发生率亦无显著差异,其他次要终点均无显著差异。
要点
- 在919例符合条件的机械通气GBS成人患者中,654例(71%)接受了气管切开,其中136例(15%)为早期气管切开(通气7天内)。
- 经稳定化逆概率治疗加权后,早期气管切开与住院死亡率降低无关(风险差0.4%;95%CI -5.6至6.7%)。
- 28天死亡率(风险差-1.3%;95%CI -3.5至0.9%)和院内肺炎发生率(风险差-2.6%;95%CI -9.1至4.2%)在早期气管切开组与对照组间均无显著差异。
- 其他次要终点(住院时长、ICU时长、机械通气时长、镇静/镇痛/谵妄时长及总住院费用)在两组间均无显著差异。
- 机械通气至气管切开的中位时间为12天(四分位距8-15天)。
适用人群与场景
- 日本诊断程序组合全国住院数据库中,2010年7月1日至2018年3月31日期间住院的成人吉兰-巴雷综合征患者。
- 纳入标准:入院首周内启动机械通气,且机械通气持续超过1周。
诊断标准与关键阈值
- 早期气管切开定义为机械通气开始后7天内行气管切开。
研究设计与关键结果
- 研究类型:回顾性观察性研究,基于日本全国住院数据库,共纳入919例符合条件的成人吉兰-巴雷综合征机械通气患者。
- 气管切开情况:654例(71%)接受气管切开,其中136例(15%)为早期气管切开;机械通气至气管切开的中位时间为12天(四分位距8-15天)。
- 主要终点:经稳定化逆概率治疗加权后,早期气管切开与住院死亡率降低无关(风险差0.4%;95%CI -5.6至6.7%)。
- 次要终点:28天死亡率(风险差-1.3%;95%CI -3.5至0.9%)和院内肺炎发生率(风险差-2.6%;95%CI -9.1至4.2%)在两组间均无显著差异;其他次要终点(住院时长、ICU时长、机械通气时长、镇静时长、镇痛时长、谵妄时长及总住院费用)亦均无显著差异。
证据类型、等级与局限
- 证据类型:回顾性观察性研究(全国住院数据库分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于机械通气超过1周的成人吉兰-巴雷综合征患者,早期气管切开(通气7天内)与住院死亡率、28天死亡率及院内肺炎发生率无显著关联,其他次要终点亦无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with Guillain-Barré syndrome (GBS) who require mechanical ventilation (MV) are regarded as candidates for early tracheostomy because of the high risk of prolonged MV; however, the association between early tracheostomy and favorable outcomes in patients with GBS remains unclear. In this study, we evaluated the association between early tracheostomy and outcomes in mechanically ventilated patients with GBS.
METHODS: This retrospective observational study included adult patients with GBS identified in the Japanese Diagnosis Procedure Combination national inpatient database from July 1, 2010, to March 31, 2018, who initiated MV within the first week of admission and who received MV for more than 1 week. Early tracheostomy was defined as tracheostomy performed within 7 days of MV. The primary outcome was in-hospital mortality, and the secondary outcomes were 28-day mortality, nosocomial pneumonia, length of hospital stay, length of intensive care unit (ICU) stay, duration of MV, duration of sedation, duration of analgesia, duration of delirium, and total hospitalization costs. Propensity scores for early tracheostomy were calculated using a logistic regression model on the following variables: age; sex; body mass index; Japan Coma Scale status at admission; Charlson comorbidity index score; comorbidity of chronic pulmonary disease; complication of pneumonia at admission; complication of hyponatremia at admission; neurological presentation at admission; ambulance use; referral from other hospitals; treatment year; days from hospital admission to MV initiation; ICU admission until the day of MV initiation; and treatments until the day of MV initiation. Stabilized inverse probability of treatment weighting analyses was performed to compare the outcomes between patients with and without early tracheostomy.
RESULTS: Among 919 eligible patients, 654 patients (71%) underwent tracheostomy, with 136 patients (15%) receiving early tracheostomy. Overall, the median time from initiation of MV to tracheostomy was 12 days (interquartile range 8-15 days). After stabilized inverse probability of treatment weighting, early tracheostomy was not associated with lower in-hospital mortality (risk difference 0.4%; 95% confidence interval - 5.6 to 6.7%) compared with patients without early tracheostomy. There were no significant differences in 28-day mortality (risk difference - 1.3%; 95% confidence interval - 3.5 to 0.9%) and incidence of nosocomial pneumonia (risk difference - 2.6%; 95% confidence interval - 9.1 to 4.2%) between the two groups. None of the other secondary outcomes differed significantly between the groups.
CONCLUSIONS: Early tracheostomy was not significantly associated with decreased mortality or morbidity in patients with GBS requiring MV for more than 1 week.
参考来源
- Yonezawa N, Jo T, Matsui H, et al. Effect of Early Tracheostomy on Mortality of Mechanically Ventilated Patients with Guillain-Barré Syndrome: A Nationwide Observational Study. Neurocrit Care. 2020. PMID: 32291575. doi:10.1007/s12028-020-00965-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。